Buckland Partners Management Co LLC
Position in GPCR — Structure Therapeutics Inc.
CIK 2074628
HARRISON, NY
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,410,000
-$1,067,500 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Buckland Partners Management Co LLC holds $3,601,600 across 2 Biotechnology names. GPCR ranks #1 (66.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GPCR |
Structure Therapeutics Inc.
This page
|
50,000 | $2,410,000 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
30,000 | $1,191,600 |
All Filings in GPCR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,410,000 | 50,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,477,500 | 50,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||